LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: The Role of New IL-1 Family Members (IL-36 and IL-38) in Atopic Dermatitis, Allergic Asthma, and Allergic Rhinitis.

    Tsang, Miranda Sin-Man / Sun, Xiaoyu / Wong, Chun Kwok

    Current allergy and asthma reports

    2020  Volume 20, Issue 8, Page(s) 40

    Abstract: Purpose of review: Since the discovery of its very first member in 1974, the IL-1 family has expanded into a group of 11 potent molecules which are essential in both innate and acquired immunity. Pro-inflammatory cytokines IL-36α, IL-36β, and IL-36γ and ...

    Abstract Purpose of review: Since the discovery of its very first member in 1974, the IL-1 family has expanded into a group of 11 potent molecules which are essential in both innate and acquired immunity. Pro-inflammatory cytokines IL-36α, IL-36β, and IL-36γ and their receptor antagonists IL-36Ra and IL-38, which belong to the IL-36 subfamily, are some of the most recently identified members. Recent studies show that these members possess pro-inflammatory and anti-inflammatory activities and may take part in the pathogenesis of allergy. In this review, the involvement and importance of these newly described IL-1 family members in the most common allergic diseases, i.e., atopic dermatitis (AD), allergic asthma, and allergic rhinitis, will be discussed.
    Recent findings: Dysregulation of IL-36 and IL-38 was observed in the skin and respiratory tract of AD, allergic rhinitis, and allergic asthma individuals. Although the upregulation in IL-36α and IL-36γ observed in the lesional skin of AD patients was unexpectedly small, IL-36 may play an important role in AD pathogenesis especially upon Staphylococcus aureus colonization. While IL-36γ regulates eosinophils to induce an inflammatory response in allergic rhinitis, IL-36α was found to regulate Th17 immunity. IL-36 receptor antagonists, IL-36Ra and IL-38, however, both show promising anti-inflammatory activities against allergic asthma. Of note, IL-38 in allergic asthmatic children is significantly lower than their healthy counterparts, while the anti-inflammatory effects of IL-38 in allergic asthma exacerbation upon viral-like infection were demonstrated in in vitro, HDM-induced, and humanized mice models. Dysregulated expression of IL-36 and IL-38 observed in allergic patients and mice models revealed that they may have essential roles in the pathogenesis in AD, allergic rhinitis, and allergic asthma, especially during the host defense against pathogens at inflammatory sites. Their receptor antagonists, IL-36Ra and IL-38, could also be promising biologics in the control of allergy. Since allergic diseases are phenotypically complex, contradictory data obtained in different studies may be explained if further stratification of disease endotypes is explored. Genetically modified mice model and investigation in anti-IL-36 treatment may be useful to characterize the therapeutic potential of these cytokines in the regulation of allergy in the future.
    MeSH term(s) Animals ; Asthma/genetics ; Dermatitis, Atopic/genetics ; Disease Models, Animal ; Humans ; Interleukin-1/metabolism ; Interleukins/metabolism ; Mice ; Rhinitis, Allergic/genetics ; Staphylococcus aureus/pathogenicity
    Chemical Substances IL-38 protein, human ; Interleukin-1 ; Interleukins ; interleukin 36, human
    Language English
    Publishing date 2020-06-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057370-4
    ISSN 1534-6315 ; 1529-7322
    ISSN (online) 1534-6315
    ISSN 1529-7322
    DOI 10.1007/s11882-020-00937-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Functional interaction between sensory neurons and mast cells in the early stage of house dust mite-induced type 2 inflammation and itch: a novel therapeutic target of allergic disease.

    Tsang, Miranda Sin-Man / Wong, Chun Kwok

    Cellular & molecular immunology

    2020  Volume 17, Issue 9, Page(s) 899–900

    MeSH term(s) Allergens ; Animals ; Inflammation ; Mast Cells ; Nociceptors ; Pyroglyphidae/immunology
    Chemical Substances Allergens
    Keywords covid19
    Language English
    Publishing date 2020-07-22
    Publishing country China
    Document type Journal Article ; Comment
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-020-0508-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Immune modulation by rural exposures and allergy protection.

    Xing, Yuhan / Tsang, Miranda Sin-Man / Yang, Zhaowei / Wang, Maggie Haitian / Pivniouk, Vadim / Leung, Agnes Sze-Yin / Leung, Ting-Fan / Roponen, Marjut / Schaub, Bianca / Vercelli, Donata / Wong, Chun-Kwok / Li, Jing / Wong, Gary Wing-Kin

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

    2024  Volume 35, Issue 2, Page(s) e14086

    Abstract: Background: Growing up on traditional farms protects children from the development of asthma and allergies. However, we have identified distinct asthma-protective factors, such as poultry exposure. This study aims to examine the biological effect of ... ...

    Abstract Background: Growing up on traditional farms protects children from the development of asthma and allergies. However, we have identified distinct asthma-protective factors, such as poultry exposure. This study aims to examine the biological effect of rural exposure in China.
    Methods: We recruited 67 rural children (7.4 ± 0.9 years) and 79 urban children (6.8 ± 0.6 years). Depending on the personal history of exposure to domestic poultry (DP), rural children were further divided into those with DP exposure (DP
    Results: There was a stepwise increase in the percentage of eosinophils (%) from rural DP
    Conclusions: Immune responses of rural children were dampened compared to urban children and those exposed to DP had further downregulated immune responsiveness. DP dust extracts ameliorated Th2-driven allergic airway inflammation in mice. Determining active protective components in the rural environment may provide directions for the development of primary prevention of asthma.
    MeSH term(s) Child ; Humans ; Animals ; Mice ; Lipopolysaccharides/adverse effects ; Hypersensitivity ; Asthma ; Allergens ; Cytokines/metabolism ; Dust ; Inflammation ; Disease Models, Animal ; Immunity ; Mice, Inbred BALB C ; Ovalbumin/adverse effects
    Chemical Substances Lipopolysaccharides ; Allergens ; Cytokines ; Dust ; Ovalbumin (9006-59-1)
    Language English
    Publishing date 2024-02-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1057059-7
    ISSN 1399-3038 ; 0905-6157 ; 0906-5784
    ISSN (online) 1399-3038
    ISSN 0905-6157 ; 0906-5784
    DOI 10.1111/pai.14086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Immunological Roles of NLR in Allergic Diseases and Its Underlying Mechanisms.

    Tsang, Miranda Sin-Man / Hou, Tianheng / Chan, Ben Chung-Lap / Wong, Chun Kwok

    International journal of molecular sciences

    2021  Volume 22, Issue 4

    Abstract: Our understanding on the immunological roles of pathogen recognition in innate immunity has vastly increased over the past 20 years. Nucleotide-binding oligomerization domain (NOD)-like receptors (NLR) are cytosolic pattern recognition receptors (PRR) ... ...

    Abstract Our understanding on the immunological roles of pathogen recognition in innate immunity has vastly increased over the past 20 years. Nucleotide-binding oligomerization domain (NOD)-like receptors (NLR) are cytosolic pattern recognition receptors (PRR) that are responsible for sensing microbial motifs and endogenous damage signals in mammalian cytosol for immune surveillance and host defense. The accumulating discoveries on these NLR sensors in allergic diseases suggest that the pathogenesis of allergic diseases may not be confined to the adaptive immune response. Therapy targeting NLR in murine models also shields light on its potential in the treatment of allergies in man. In this review, we herein summarize the recent understanding of the role of NLR sensors and their molecular mechanisms involved in allergic inflammation, including atopic dermatitis and allergic asthma.
    MeSH term(s) Animals ; Humans ; Hypersensitivity/immunology ; Hypersensitivity/metabolism ; Inflammasomes/metabolism ; NLR Proteins/immunology ; NLR Proteins/metabolism
    Chemical Substances Inflammasomes ; NLR Proteins
    Language English
    Publishing date 2021-02-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22041507
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Novel insights into the role of anti-inflammatory IL-38 in immunity against infection.

    Gao, Xun / Wu, Guoqiu / Tsang, Miranda Sin-Man / Huang, Danqi / Lam, Christopher Wai-Kei / Wong, Chun Kwok

    Cellular & molecular immunology

    2022  Volume 19, Issue 11, Page(s) 1322–1324

    MeSH term(s) Cytokines ; Interferon-gamma ; Anti-Inflammatory Agents ; Immunity, Innate
    Chemical Substances Cytokines ; Interferon-gamma (82115-62-6) ; Anti-Inflammatory Agents
    Language English
    Publishing date 2022-08-16
    Publishing country China
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-022-00876-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice.

    Kan, Lea Ling-Yu / Chan, Ben Chung-Lap / Yue, Grace Gar-Lee / Li, Peiting / Hon, Sharon Sze-Man / Huang, Danqi / Tsang, Miranda Sin-Man / Lau, Clara Bik-San / Leung, Ping-Chung / Wong, Chun-Kwok

    Chinese journal of integrative medicine

    2023  Volume 30, Issue 4, Page(s) 311–321

    Abstract: Objective: To investigate the in vivo immunomodulatory and anti-tumor mechanisms of the combined treatment of novel Four-Herb formula (4HF) and doxorubicin in triple-negative breast cancer (TNBC).: Methods: Murine-derived triple-negative mammary ... ...

    Abstract Objective: To investigate the in vivo immunomodulatory and anti-tumor mechanisms of the combined treatment of novel Four-Herb formula (4HF) and doxorubicin in triple-negative breast cancer (TNBC).
    Methods: Murine-derived triple-negative mammary carcinoma cell line, 4T1 cells, was cultured and inoculated into mouse mammary glands. Sixty-six mice were randomly assigned into 6 groups (n=11 in ench): naïve, control, LD 4HF (low dose 4HF), HD 4HF (high dose 4HF), LD 4HF + D (low dose and doxorubicin), and D (doxorubicin). Apart from the naïve group, each mouse received subcutaneous inoculation with 5 × 10
    Results: Mice treated with the combination of 4HF and doxorubicin resulted in significantly reduced tumor and spleen burdens (P<0.05), altered the hypoxia and overall immune lymphocyte landscape, and manipulated gut microbiota to favor the anti-tumor immunological activities. Moreover, immunosuppressive genes, cytokines, and chemokines such as C-C motif chemokine 2 and interleukin-10 of tumors were significantly downregulated (P<0.05). 4HF-doxorubicin combination treatment demonstrated synergetic activities and was most effective in activating the anti-tumor immune response (P<0.05).
    Conclusion: The above results provide evidence for evaluating the immune regulating mechanisms of 4HF in breast cancer and support its clinical significance in its potential as an adjunctive therapeutic agent or immune supplement.
    MeSH term(s) Animals ; Mice ; Saline Solution ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Combined Modality Therapy ; Immunity ; Water ; Mice, Inbred BALB C ; Cell Line, Tumor ; Neoplasms/drug therapy
    Chemical Substances Saline Solution ; Doxorubicin (80168379AG) ; Water (059QF0KO0R)
    Language English
    Publishing date 2023-08-18
    Publishing country China
    Document type Journal Article
    ZDB-ID 2171254-2
    ISSN 1993-0402 ; 1672-0415
    ISSN (online) 1993-0402
    ISSN 1672-0415
    DOI 10.1007/s11655-023-3745-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: IL-37 Targets TSLP-Primed Basophils to Alleviate Atopic Dermatitis.

    Hou, Tianheng / Tsang, Miranda Sin-Man / Kan, Lea Ling-Yu / Li, Peiting / Chu, Ida Miu-Ting / Lam, Christopher Wai-Kei / Wong, Chun-Kwok

    International journal of molecular sciences

    2021  Volume 22, Issue 14

    Abstract: Atopic dermatitis (AD) represents a severe global burden on physical, physiological and mental health. Innate immune cell basophils are essential for provoking allergic inflammation in AD. However, the roles of novel immunoregulatory cytokine IL-37 in ... ...

    Abstract Atopic dermatitis (AD) represents a severe global burden on physical, physiological and mental health. Innate immune cell basophils are essential for provoking allergic inflammation in AD. However, the roles of novel immunoregulatory cytokine IL-37 in basophils remain elusive. We employed in vitro co-culture of human basophils and human keratinocyte HaCaT cells and an in vivo MC903-induced AD murine model to investigate the anti-inflammatory mechanism of IL-37. In the in vitro model, IL-37b significantly decreased Der p1-induced thymic stromal lymphopoietin (TSLP) overexpression in HaCaT cells and decreased the expression of TSLP receptor as well as basophil activation marker CD203c on basophils. IL-37 could also reduce Th2 cytokine IL-4 release from TSLP-primed basophils ex vivo. In the in vivo model, alternative depletion of basophils ameliorated AD symptoms and significantly lowered the Th2 cell and eosinophil populations in the ear and spleen of the mice. Blocking TSLP alleviated the AD-like symptoms and reduced the infiltration of basophils in the spleen. In CRISPR/Cas9 human IL-37b knock-in mice or mice with direct treatment by human IL-37b antibody, AD symptoms including ear swelling and itching were significantly alleviated upon MC903 challenge. Notably, IL-37b presence significantly reduced the basophil infiltration in ear lesions. In summary, IL-37b could regulate the TSLP-mediated activation of basophils and reduce the release of IL-4. The results, therefore, suggest that IL-37 may target TSLP-primed basophils to alleviate AD.
    MeSH term(s) Animals ; Anti-Inflammatory Agents/therapeutic use ; Basophils/drug effects ; Basophils/immunology ; Cell Line ; Coculture Techniques ; Cytokines/antagonists & inhibitors ; Cytokines/metabolism ; Cytokines/pharmacology ; Dermatitis, Atopic/drug therapy ; Dermatitis, Atopic/genetics ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/metabolism ; Down-Regulation ; Ear/pathology ; Eosinophils/metabolism ; Gene Knock-In Techniques ; Humans ; Interleukin-1/genetics ; Interleukin-1/metabolism ; Interleukin-1/pharmacology ; Interleukin-1/therapeutic use ; Interleukin-4/metabolism ; Keratinocytes/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Phosphoric Diester Hydrolases/metabolism ; Pyrophosphatases/metabolism ; Spleen/immunology ; Spleen/metabolism ; Th2 Cells/immunology ; Up-Regulation
    Chemical Substances Anti-Inflammatory Agents ; Cytokines ; ENPP3 protein, human ; IL37 protein, human ; Interleukin-1 ; Interleukin-4 (207137-56-2) ; Phosphoric Diester Hydrolases (EC 3.1.4.-) ; Pyrophosphatases (EC 3.6.1.-) ; thymic stromal lymphopoietin (GT0IL38SP4)
    Language English
    Publishing date 2021-07-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22147393
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: The Active Compounds and Therapeutic Mechanisms of Pentaherbs Formula for Oral and Topical Treatment of Atopic Dermatitis Based on Network Pharmacology

    Chu, Man / Tsang, Miranda Sin-Man / He, Ru / Lam, Christopher Wai-Kei / Quan, Zhi Bo / Wong, Chun Kwok

    Plants. 2020 Sept. 09, v. 9, no. 9

    2020  

    Abstract: To examine the molecular targets and therapeutic mechanism of a clinically proven Chinese medicinal pentaherbs formula (PHF) in atopic dermatitis (AD), we analyzed the active compounds and core targets, performed network and molecular docking analysis, ... ...

    Abstract To examine the molecular targets and therapeutic mechanism of a clinically proven Chinese medicinal pentaherbs formula (PHF) in atopic dermatitis (AD), we analyzed the active compounds and core targets, performed network and molecular docking analysis, and investigated interacting pathways. Information on compounds in PHF was obtained from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, and target prediction was performed using the Drugbank database. AD-related genes were gathered using the GeneCards and Online Mendelian Inheritance in Man (OMIM) databases. Network analysis was performed by Cytoscape software and protein-protein interaction was analyzed by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). The Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources were applied for the enrichment analysis of the potential biological process and pathways associated with the intersection targets between PHF and AD. Autodock software was used to perform protein compound docking analysis. We identified 43 active compounds in PHF associated with 117 targets, and 57 active compounds associated with 107 targets that form the main pathways linked to oral and topical treatment of AD, respectively. Among them, quercetin, luteolin, and kaempferol are key chemicals targeting the core genes involved in the oral use of PHF against AD, while apigenin, ursolic acid, and rosmarinic acid could be used in topical treatment of PHF against AD. The compound–target–disease network constructed in the current study reveals close interactions between multiple components and multiple targets. Enrichment analysis further supports the biological processes and signaling pathways identified, indicating the involvement of IL-17 and tumor necrosis factor signaling pathways in the action of PHF on AD. Our data demonstrated the main compounds and potential pharmacological mechanisms of oral and topical application of PHF in AD.
    Keywords Mendelian inheritance ; Oriental traditional medicine ; active ingredients ; apigenin ; atopic dermatitis ; bioinformatics ; computer simulation ; computer software ; databases ; genes ; interleukin-17 ; kaempferol ; luteolin ; pharmacology ; prediction ; protein-protein interactions ; proteins ; quercetin ; rosmarinic acid ; signal transduction ; topical application ; tumor necrosis factors ; ursolic acid
    Language English
    Dates of publication 2020-0909
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2704341-1
    ISSN 2223-7747
    ISSN 2223-7747
    DOI 10.3390/plants9091166
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant

    Chan, Ben Chung-Lap / Li, Peiting / Tsang, Miranda Sin-Man / Sung, Johnny Chun-Chau / Kwong, Keith Wai-Yeung / Zheng, Tao / Hon, Sharon Sze-Man / Lau, Ching-Po / Cheng, Wen / Chen, Fang / Lau, Clara Bik-San / Leung, Ping-Chung / Wong, Chun-Kwok

    Molecules (Basel, Switzerland)

    2023  Volume 28, Issue 13

    Abstract: Vaccination is the most effective method of combating COVID-19 infection, but people with a psychological fear of needles and side effects are hesitant to receive the current vaccination, and alternative delivery methods may help. ...

    Abstract Vaccination is the most effective method of combating COVID-19 infection, but people with a psychological fear of needles and side effects are hesitant to receive the current vaccination, and alternative delivery methods may help.
    MeSH term(s) Humans ; Mice ; Animals ; COVID-19 Vaccines ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/metabolism ; Bacillus subtilis/genetics ; Bacillus subtilis/metabolism ; Biological Products/metabolism ; Spores, Bacterial/metabolism ; COVID-19/prevention & control ; COVID-19/metabolism ; SARS-CoV-2 ; Vaccines ; Immunity, Innate
    Chemical Substances sinovac COVID-19 vaccine ; COVID-19 Vaccines ; spike protein, SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Biological Products ; Vaccines
    Language English
    Publishing date 2023-06-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules28134996
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Adjuvant activities of immunostimulating natural products: Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infection.

    Chan, Ben Chung-Lap / Li, Peiting / Tsang, Miranda Sin-Man / Sung, Johnny Chun-Chau / Kwong, Keith Wai-Yeung / Zheng, Tao / Hon, Sharon Sze-Man / Lau, Ching-Po / Ho, Ronald Chi-Yan / Chen, Fang / Lau, Clara Bik-San / Leung, Ping-Chung / Wong, Chun-Kwok

    Journal of leukocyte biology

    2023  Volume 115, Issue 1, Page(s) 177–189

    Abstract: The global pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been developing all over the world for more than 3 years. In late 2020, several variants of concern of SARS-CoV-2 virus emerged, with increased ... ...

    Abstract The global pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been developing all over the world for more than 3 years. In late 2020, several variants of concern of SARS-CoV-2 virus emerged, with increased viral fitness and transmissibility by mutations of the spike proteins of the viral particle, denting hopes of the use of early-generation vaccines for a widespread protective immunity against viral infection. The use of adjuvants may enhance the immune responses of the conventional application of the COVID-19 vaccine. We have shown that the water extract of 2 β-glucan-enriched immunostimulating natural products, Astragalus membranaceus (Fisch.) Bge. (AM) and Coriolus versicolor (CV), could induce innate immunity-related cytokines from human monocytes (CCL5, interleukin [IL]-6, IL-10, and tumor necrosis factor α) and monocyte-derived dendritic cells (IL-1β, IL-10, IL-12, and tumor necrosis factor α). Using BALB/c mice, orally administrated AM and CV (1,384 and 742 mg/kg/d) for 4 d after vaccination, respectively, could enhance (1) the immunoglobulin G binding activities of BNT162b2 vaccination against ancestral and Delta SARS-CoV-2 spike proteins by 5.8- and 4.3-fold, respectively; (2) the immunoglobulin G3 subclass production of BNT162b2 vaccination against ancestral and variant SARS-CoV-2 spike proteins; and (3) the in vitro antibody-neutralizing activities of BNT162b2 vaccinated mice. In conclusion, combining AM and CV was effective in acting as an oral adjuvant with the messenger RNA vaccine BNT162b2 to improve the antigen binding activities against SARS-CoV-2 ancestral and variant SARS-CoV-2 spike proteins, probably via trained immunity of macrophages and dendritic cells.
    MeSH term(s) Humans ; Animals ; Mice ; BNT162 Vaccine ; COVID-19/prevention & control ; Astragalus propinquus ; Interleukin-10 ; Spike Glycoprotein, Coronavirus ; Biological Products ; COVID-19 Vaccines ; Tumor Necrosis Factor-alpha ; SARS-CoV-2 ; Adjuvants, Immunologic/pharmacology ; Vaccination ; Antibodies, Neutralizing ; Antibodies, Viral
    Chemical Substances BNT162 Vaccine ; Interleukin-10 (130068-27-8) ; Spike Glycoprotein, Coronavirus ; Biological Products ; COVID-19 Vaccines ; Tumor Necrosis Factor-alpha ; Adjuvants, Immunologic ; Antibodies, Neutralizing ; Antibodies, Viral ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2023-09-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605722-6
    ISSN 1938-3673 ; 0741-5400
    ISSN (online) 1938-3673
    ISSN 0741-5400
    DOI 10.1093/jleuko/qiad106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top